Functions of the aryl hydrocarbon receptor in the skin

Schmidt JV, Bradfield CA (1996) Ah receptor signaling pathways. Annu Rev Cell Dev Biol 12:55–89 Dolwick KM, Schmidt JV, Carver LA, Swanson HI, Bradfield CA (1993) Cloning and expression of a human Ah receptor cDNA. Mol Pharmacol 44(5):911–917 Abel J, Haarmann-Stemmann T (2010) An introduction to the molecular basics of aryl hydrocarbon receptor biology. Biol Chem 391(11):1235–1248 Sun YV, Boverhof DR, Burgoon LD, Fielden MR, Zacharewski TR (2004) Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. Nucleic Acids Res 32(15):4512–4523 Frericks M, Meissner M, Esser C (2007) Microarray analysis of the AHR system: tissue-specific flexibility in signal and target genes. Toxicol Appl Pharmacol 220(3):320–332 Mitchell KA, Elferink CJ (2009) Timing is everything: consequences of transient and sustained AhR activity. Biochem Pharmacol 77(6):947–956 Wu D, Li W, Lok P, Matsumura F, dam Vogel CF (2011) AhR deficiency impairs expression of LPS-induced inflammatory genes in mice. Biochem Biophys Res Commun 410(2):358–363 Fritsche E, Schafer C, Calles C, Bernsmann T, Bernshausen T, Wurm M et al (2007) Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc Natl Acad Sci USA 104(21):8851–8856 Mimura J, Ema M, Sogawa K, Fujii-Kuriyama Y (1999) Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev 13(1):20–25 Tigges J, Weighardt H, Wolff S, Gotz C, Forster I, Kohne Z, et al. (2012) Aryl Hydrocarbon Receptor Repressor (AhRR) function revisited: repression of CYP1 activity in human skin fibroblasts is not related to AhRR expression. J Invest Dermatol Romani N, Clausen BE, Stoitzner P (2010) Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev 234(1):120–141 Clark RA, Chong B, Mirchandani N, Brinster NK, Yamanaka K, Dowgiert RK et al (2006) The vast majority of CLA + T cells are resident in normal skin. J Immunol 176(7):4431–4439 Nestle FO, Di MP, Qin JZ, Nickoloff BJ (2009) Skin immune sentinels in health and disease. Nat Rev Immunol 9(10):679–691 Carlstedt-Duke JM (1979) Tissue distribution of the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Cancer Res 39(8):3172–3176 Li W, Donat S, Dohr O, Unfried K, Abel J (1994) Ah receptor in different tissues of C57BL/6 J and DBA/2 J mice: use of competitive polymerase chain reaction to measure Ah-receptor mRNA expression. Arch Biochem Biophys 315(2):279–284 Esser C (2012) The physiological role of AHR in the mouse immune system. In: Pojhanvirta R (ed) The AH receptor in biology and toxicology. Ref Type: Serial (Book,Monograph). Wiley&Sons, Hoboken, pp 499–510 Denison MS, Nagy SR (2003) Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43:309–334 Nguyen LP, Bradfield CA (2008) The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 21(1):102–116 Denison MS, Soshilov AA, He G, DeGroot DE, Zhao B (2011) Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol Sci 124(1):1–22 Rannug U, Rannug A, Sjoberg U, Li H, Westerholm R, Bergman J (1995) Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem Biol 2(12):841–845 Rannug A, Rannug U, Rosenkranz HS, Winqvist L, Westerholm R, Agurell E et al (1987) Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances. J Biol Chem 262(32):15422–15427 Diani-Moore S, Labitzke E, Brown R, Garvin A, Wong L, Rifkind AB (2006) Sunlight generates multiple tryptophan photoproducts eliciting high-efficacy CYP1A induction in chick hepatocytes and in vivo. Toxicol Sci 90(1):96–110 Wincent E, Amini N, Luecke S, Glatt H, Bergman J, Crescenzi C et al (2009) The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-formylindolo[3,2-b]carbazole is present in humans. J Biol Chem 284(5):2690–2696 Veldhoen M, Hirota K, Christensen J, O’Garra A, Stockinger B (2009) Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J Exp Med 206(1):43–49 Diani-Moore S, Ma Y, Labitzke E, Tao H, David WJ, Anderson J et al (2011) Discovery and biological characterization of 1-(1H-indol-3-yl)-9H-pyrido[3,4-b]indole as an aryl hydrocarbon receptor activator generated by photoactivation of tryptophan by sunlight. Chem Biol Interact 193(2):119–128 Hahn ME (2002) Aryl hydrocarbon receptors: diversity and evolution. Chem Biol Interact 141(1–2):131–160 Katiyar SK, Matsui MS, Mukhtar H (2000) Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. J Invest Dermatol 114(2):328–333 Ma Q, Lu AY (2007) CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies. Drug Metab Dispos 35(7):1009–1016 Modi BG, Neustadter J, Binda E, Lewis J, Filler RB, Roberts SJ et al (2012) Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma. Science 335(6064):104–108 Martin R, O’Shea J, Birnbaum LS, Luebke R (2008) Community corner. Striking the balance in multiple sclerosis. Nat Med 14(5):491 Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA (2010) An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol 185(6):3190–3198 Asp L, Johansson AS, Mann A, Owe-Larsson B, Urbanska EM, Kocki T et al (2011) Effects of proinflammatory cytokines on expression of kynurenine pathway enzymes in human dermal fibroblasts. J Inflamm (Lond) 8:25 Jux B, Kadow S, Esser C (2009) Langerhans cell maturation and contact hypersensitivity are impaired in aryl hydrocarbon receptor-null mice. J Immunol 182(11):6709–6717 Nguyen NT, Kimura A, Nakahama T, Chinen I, Masuda K, Nohara K et al (2010) Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci U S A 107(46):19961–19966 Mellor AL, Munn DH (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4(10):762–774 Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196(4):459–468 Schallreuter KU, Salem MA, Gibbons NC, Maitland DJ, Marsch E, Elwary SM et al (2012) Blunted epidermal l-tryptophan metabolism in vitiligo affects immune response and ROS scavenging by Fenton chemistry, part 2: epidermal H2O2/ONOO(−)-mediated stress in vitiligo hampers indoleamine 2,3-dioxygenase and aryl hydrocarbon receptor-mediated immune response signaling. FASEB J 26(6):2471–2485 Wille G, Mayser P, Thoma W, Monsees T, Baumgart A, Schmitz HJ et al (2001) Malassezin–A novel agonist of the arylhydrocarbon receptor from the yeast Malassezia furfur. Bioorg Med Chem 9(4):955–960 Vlachos C, Schulte BM, Magiatis P, Adema GJ, Gaitanis G (2012) Malassezia-derived indoles activate the aryl hydrocarbon receptor and inhibit toll-like receptor-induced maturation in monocyte-derived dendritic cells. Br J Dermatol 167(3):496–505 Gaitanis G, Velegraki A, Magiatis P, Pappas P, Bassukas ID (2011) Could Malassezia yeasts be implicated in skin carcinogenesis through the production of aryl-hydrocarbon receptor ligands? Med Hypotheses 77(1):47–51 Jin UH, Lee SO, Safe S (2012) Aryl hydrocarbon receptor (AHR)-active pharmaceuticals are selective AHR modulators in MDA-MB-468 and BT474 breast cancer cells. J Pharmacol Exp Ther 343(2):333–341 Tiong CT, Chen C, Zhang SJ, Li J, Soshilov A, Denison MS et al (2012) A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERalpha protein. Carcinogenesis 33(5):1089–1097 Caputo R, Monti M, Ermacora E, Carminati G, Gelmetti C, Gianotti R et al (1988) Cutaneous manifestations of tetrachlorodibenzo-p-dioxin in children and adolescents. Follow-up 10 years after the Seveso, Italy, accident. J Am Acad Dermatol 19(5 Pt 1):812–819 Scholz A (2012) Karl Herxheimer - Geheimrat mit dem gelben Stern. J Dtsch Dermatol Ges 10(12):925–927 Passarini B, Infusino SD, Kasapi E (2010) Chloracne: still cause for concern. Dermatology 221(1):63–70 Saurat JH, Kaya G, Saxer-Sekulic N, Pardo B, Becker M, Fontao L et al (2012) The cutaneous lesions of dioxin exposure: lessons from the poisoning of Victor Yushchenko. Toxicol Sci 125(1):310–317 Gotz C, Pfeiffer R, Tigges J, Blatz V, Jackh C, Freytag EM et al (2012) Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I). Exp Dermatol 21(5):358–363 Kikuchi M (1984) Autopsy of patients with yusho. Prog Clin Biol Res 137:19–30 Kanagawa Y, Matsumoto S, Koike S, Tajima B, Fukiwake N, Shibata S et al (2008) Association of clinical findings in Yusho patients with serum concentrations of polychlorinated biphenyls, polychlorinated quarterphenyls, and 2,3,4,7,8-pentachlorodibenzofuran more than 30 years after the poisoning event. Environ Health 7:47 Masuda Y (1985) Health status of Japanese and Taiwanese after exposure to contaminated rice oil. Environ Health Perspect 60:321–325 Hashiguchi I, Yoshimine Y, Maeda H, Gotou Y, Ishikawa M, Fujii S et al (2007) Epidemiologic examination on the prevalence of the periodontal diseases and oral pigmentation in Yusho patients in 2006. Fukuoka Igaku Zasshi 98(5):170–175 Dunagin WG (1984) Cutaneous signs of systemic toxicity due to dioxins and related chemicals. J Am Acad Dermatol 10(4):688–700 Jux B, Kadow S, Luecke S, Rannug A, Krutmann J, Esser C (2011) The aryl hydrocarbon receptor mediates UVB radiation-induced skin tanning. J Invest Dermatol 131(1):203–210 Kiss EA, Vonarbourg C, Kopfmann S, Hobeika E, Finke D, Esser C et al (2011) Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science. doi:10.1126/science.1214914 Luecke S, Backlund M, Jux B, Esser C, Krutmann J, Rannug A (2010) The aryl hydrocarbon receptor (AHR), a novel regulator of human melanogenesis. Pigment Cell Melanoma Res 23(6):828–833 Wang XW, Li K, Guo S, Qiang HN, Liu L, Song P et al (2012) The association of functional polymorphisms in the aryl hydrocarbon receptor (AHR) gene with the risk of vitiligo in Han Chinese populations. Br J Dermatol 166(5):1081–1087 Kitamura R, Tsukamoto K, Harada K, Shimizu A, Shimada S, Kobayashi T et al (2004) Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M. J Pathol 202(4):463–475 Andersson P, McGuire J, Rubio C, Gradin K, Whitelaw ML, Pettersson S et al (2002) A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc Natl Acad Sci U S A 99(15):9990–9995 Moennikes O, Loeppen S, Buchmann A, Andersson P, Ittrich C, Poellinger L et al (2004) A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Res 64(14):4707–4710 Haarmann-Stemmann T, Bothe H, Abel J (2009) Growth factors, cytokines, and their receptors as downstream targets of aryl hydrocarbon receptor (AhR) signaling pathways. Biochem Pharmacol 77(4):508–520 Tauchi M, Hida A, Negishi T, Katsuoka F, Noda S, Mimura J et al (2005) Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions. Mol Cell Biol 25(21):9360–9368 Xue W, Warshawsky D (2005) Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol Appl Pharmacol 206(1):73–93 Godschalk R, Curfs D, Bartsch H, van Schooten FJ, Nair J (2003) Benzo[a]pyrene enhances lipid peroxidation induced DNA damage in aorta of apolipoprotein E knockout mice. Free Radic Res 37(12):1299–1305 Diepgen TL, Mahler V (2002) The epidemiology of skin cancer. Br J Dermatol 146(Suppl 61):1–6 Gelboin HV (1980) Benzo[alpha]pyrene metabolism, activation, and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 60(4):1107–1166 Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, Mimura J et al (2000) Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 97(2):779–782 Ide F, Suka N, Kitada M, Sakashita H, Kusama K, Ishikawa T (2004) Skin and salivary gland carcinogenicity of 7,12-dimethylbenz[a]anthracene is equivalent in the presence or absence of aryl hydrocarbon receptor. Cancer Lett 214(1):35–41 Hennings H, Devor D, Wenk ML, Slaga TJ, Former B, Colburn NH et al (1981) Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N’-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. Cancer Res 41(3):773–779 Balmain A, Ramsden M, Bowden GT, Smith J (1984) Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 307(5952):658–660 Buters J, Quintanilla-Martinez L, Schober W, Soballa VJ, Hintermair J, Wolff T et al (2003) CYP1B1 determines susceptibility to low doses of 7,12-dimethylbenz[a]anthracene-induced ovarian cancers in mice: correlation of CYP1B1-mediated DNA adducts with carcinogenicity. Carcinogenesis 24(2):327–334 Savas U, Carstens CP, Jefcoate CR (1997) Biological oxidations and P450 reactions. Recombinant mouse CYP1B1 expressed in Escherichia coli exhibits selective binding by polycyclic hydrocarbons and metabolism which parallels C3H10T1/2 cell microsomes, but differs from human recombinant CYP1B1. Arch Biochem Biophys 347(2):181–192 Wislocki PG, Gadek KM, Chou MW, Yang SK, Lu AY (1980) Carcinogenicity and mutagenicity of the 3,4-dihydrodiols and other metabolites of 7,12-dimethylbenz(a)anthracene and its hydroxymethyl derivatives. Cancer Res 40(10):3661–3664 Tsuchiya Y, Nakajima M, Kyo S, Kanaya T, Inoue M, Yokoi T (2004) Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res 64(9):3119–3125 Zheng W, Jefcoate CR (2005) Steroidogenic factor-1 interacts with cAMP response element-binding protein to mediate cAMP stimulation of CYP1B1 via a far upstream enhancer. Mol Pharmacol 67(2):499–512 Uno S, Dalton TP, Shertzer HG, Genter MB, Warshawsky D, Talaska G et al (2001) Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyp1a1(−/−) knockout mice having increased hepatic BaP-DNA adduct levels. Biochem Biophys Res Commun 289(5):1049–1056 Haarmann-Stemmann T, Abel J, Fritsche E, Krutmann J (2012) The AhR-Nrf2 pathway in keratinocytes: on the road to chemoprevention? J Invest Dermatol 132(1):7–9 Baird L, Dinkova-Kostova AT (2011) The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol 85(4):241–272 Xu C, Huang MT, Shen G, Yuan X, Lin W, Khor TO et al (2006) Inhibition of 7,12-Dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer Res 66(16):8293–8296 Rundhaug JE, Fischer SM (2008) Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis. Photochem Photobiol 84(2):322–329 Ciolino HP, Daschner PJ, Yeh GC (1998) Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res 58(24):5707–5712 Palermo CM, Hernando JI, Dertinger SD, Kende AS, Gasiewicz TA (2003) Identification of potential aryl hydrocarbon receptor antagonists in green tea. Chem Res Toxicol 16(7):865–872 Aziz MH, Reagan-Shaw S, Wu J, Longley BJ, Ahmad N (2005) Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB J 19(9):1193–1195 Lu YP, Lou YR, Xie JG, Peng QY, Liao J, Yang CS et al (2002) Topical applications of caffeine or (−)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc Natl Acad Sci U S A 99(19):12455–12460 Sun SY, Hail N Jr, Lotan R (2004) Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst 96(9):662–672 Rosette C, Karin M (1996) Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274(5290):1194–1197 Tran QT, Kennedy LH, Leon CS, Bodreddigari S, Goodwin SB, Sutter CH et al (2012) EGFR regulation of epidermal barrier function. Physiol Genomics 44(8):455–469 Sutter CH, Yin H, Li Y, Mammen JS, Bodreddigari S, Stevens G et al (2009) EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes. Proc Natl Acad Sci U S A 106(11):4266–4271 Takagi S, Tojo H, Tomita S, Sano S, Itami S, Hara M et al (2003) Alteration of the 4-sphingenine scaffolds of ceramides in keratinocyte-specific Arnt-deficient mice affects skin barrier function. J Clin Invest 112(9):1372–1382 Matsue H, Cruz PD Jr, Bergstresser PR, Takashima A (1992) Cytokine expression by epidermal cell subpopulations. J Invest Dermatol 99(5):42S–45S Williams IR, Kupper TS (1996) Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci 58(18):1485–1507 Lai ZW, Pineau T, Esser C (1996) Identification of dioxin-responsive elements (DREs) in the 5′ regions of putative dioxin-inducible genes. Chem Biol Interact 100(2):97–112 Henley DV, Bellone CJ, Williams DA, Ruh MF (2004) MAPK signaling pathways modulate IL-1beta expression in human keratinocytes. Arch Biochem Biophys 424(1):112–118 Tsuji G, Takahara M, Uchi H, Takeuchi S, Mitoma C, Moroi Y et al (2011) An environmental contaminant, benzo(a)pyrene, induces oxidative stress-mediated interleukin-8 production in human keratinocytes via the aryl hydrocarbon receptor signaling pathway. J Dermatol Sci 62(1):42–49 Carvajal-Gonzalez JM, Roman AC, Cerezo-Guisado MI, Rico-Leo EM, Martin-Partido G, Fernandez-Salguero PM (2009) Loss of dioxin-receptor expression accelerates wound healing in vivo by a mechanism involving TGF{beta}. J Cell Sci 122(Pt 11):1823–1833 Kissenpfennig A, Henri S, Dubois B, Laplace-Builhe C, Perrin P, Romani N et al (2005) Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22(5):643–654 Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML et al (2005) Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 169(4):569–576 Zhao X, Deak E, Soderberg K, Linehan M, Spezzano D, Zhu J et al (2003) Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med 197(2):153–162 Allan RS, Smith CM, Belz GT, van Lint AL, Wakim LM, Heath WR et al (2003) Epidermal viral immunity induced by CD8alpha + dendritic cells but not by Langerhans cells. Science 301(5641):1925–1928 Puhvel SM, Sakamoto M, Reisner RM (1989) Effect of TCDD on the density of Langerhans cells in murine skin. Toxicol Appl Pharmacol 99(1):72–80 Kadow S, Jux B, Zahner SP, Wingerath B, Chmill S, Clausen BE et al (2011) Aryl hydrocarbon receptor is critical for homeostasis of invariant gamma}{delta T cells in the murine epidermis. J Immunol 187(6):3104–3110 Kadow S, Jux B, Chmill S, Esser C (2010) Small molecules as friends and foes of the immune system. Future Med Chem 1(9):1583–1591 Merk HF, Baron JM, Heise R, Fritsche E, Schroeder P, Abel J et al (2006) Concepts in molecular dermatotoxicology. Exp Dermatol 15(9):692–704 Ito T, Inouye K, Nohara K, Tohyama C, Fujimaki H (2008) TCDD exposure exacerbates atopic dermatitis-related inflammation in NC/Nga mice. Toxicol Lett 177(1):31–37 Vogel CF, Matsumura F (2009) A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family. Biochem Pharmacol 77(4):734–745 Kimura A, Naka T, Nakahama T, Chinen I, Masuda K, Nohara K et al (2009) Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J Exp Med 206(9):2027–2035 Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC et al (2008) The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453(7191):106–109 Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E et al (2008) Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453(7191):65–71 Ito M, Ogawa K, Takeuchi K, Nakada A, Heishi M, Suto H et al (2004) Gene expression of enzymes for tryptophan degradation pathway is upregulated in the skin lesions of patients with atopic dermatitis or psoriasis. J Dermatol Sci 36(3):157–164 Voorhis MV, Fechner JH, Zhang X, Mezrich JD (2012) The Aryl hydrocarbon receptor: a novel target for immunomodulation in organ transplantation. Transplantation Apetoh L, Quintana FJ, Pot C, Joller N, Xiao S, Kumar D et al (2010) The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol 11(9):854–861 Gandhi R, Kumar D, Burns EJ, Nadeau M, Dake B, Laroni A et al (2010) Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat Immunol 11(9):846–853 Fujita H, Nograles KE, Kikuchi T, Gonzalez J, Carucci JA, Krueger JG (2009) Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc Natl Acad Sci U S A 106(51):21795–21800 Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H (2009) Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 10(8):864–871 Zhang N, Pan HF, Ye DQ (2011) Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Mol Cell Biochem 353(1–2):41–46 Wu HY, Quintana FJ, da Cunha AP, Dake BT, Koeglsperger T, Starossom SC et al (2011) In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling. PLoS One 6(8):e23618 Girardi M, Lewis JM, Filler RB, Hayday AC, Tigelaar RE (2006) Environmentally responsive and reversible regulation of epidermal barrier function by gamma delta T cells. J Invest Dermatol 126(4):808–814 Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M (2009) Interleukin-17-producing gamma delta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31(2):321–330 Li Y, Innocentin S, Withers DR, Roberts NA, Gallagher AR, Grigorieva EF et al (2011) Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell. doi:10.1016/j.cell.2011.09.025 Ebert LM, Meuter S, Moser B (2006) Homing and function of human skin gamma delta T cells and NK cells: relevance for tumor surveillance. J Immunol 176(7):4331–4336 Jameson J, Havran WL (2007) Skin gamma-delta T cell functions in homeostasis and wound healing. Immunol Rev 215:114–122 Holtmeier W, Kabelitz D (2005) Gamma-delta T cells link innate and adaptive immune responses. Chem Immunol Allergy 86:151–183 Laggner U, Di MP, Perera GK, Hundhausen C, Lacy KE, Ali N et al (2011) Identification of a novel proinflammatory human skin-homing Vgamma9Vdelta2 T cell subset with a potential role in psoriasis. J Immunol 187(5):2783–2793 Cai Y, Fleming C, Yan J (2012) New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol 9(4):302–309 Prud’homme GJ (2012) Cancer stem cells and novel targets for antitumor strategies. Curr Pharm Des 18(19):2838–2849 Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S et al (2011) An endogenous tumor-promoting ligand of the human aryl hydrocarbon receptor. Nat Geosci 478(7368):197–203 Ma Q (2011) Influence of light on aryl hydrocarbon receptor signaling and consequences in drug metabolism, physiology, and disease. Expert Opin Drug Metab Toxicol 7(10):1267–1293 Korkina LG, Pastore S, Dellambra E, De LC (2012) New molecular and cellular targets for chemoprevention and treatment of skin tumors by plant polyphenols: a critical review. Curr Med Chem Platzer B, Richter S, Kneidinger D, Waltenberger D, Woisetschlager M, Strobl H (2009) Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells. J Immunol 183(1):66–74 Sibilano R, Frossi B, Calvaruso M, Danelli L, Betto E, Dall’Agnese A et al (2012) The aryl hydrocarbon receptor modulates acute and late mast cell responses. J Immunol 189(1):120–127 Cho YC, Zheng W, Jefcoate CR (2004) Disruption of cell–cell contact maximally but transiently activates AhR-mediated transcription in 10 T1/2 fibroblasts. Toxicol Appl Pharmacol 199(3):220–238 Ju Q, Fimmel S, Hinz N, Stahlmann R, Xia L, Zouboulis CC (2011) 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters sebaceous gland cell differentiation in vitro. Exp Dermatol 20(4):320–325 Singh KP, Casado FL, Opanashuk LA, Gasiewicz TA (2009) The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem/progenitor cell populations. Biochem Pharmacol 77(4):577–587 Esser C, Rannug A, Stockinger B (2009) The aryl hydrocarbon receptor and immunity. Trends Immunol 9:447–454 Pauly SK, Fechner JH, Zhang X, Torrealba J, Bradfield CA, Mezrich JD (2012) The aryl hydrocarbon receptor influences transplant outcomes in response to environmental signals. Toxicol Environ Chem 94(6):1175–1187 Schallreuter KU, Salem MA, Gibbons NC, Martinez A, Slominski R, Ludemann J et al (2012) Blunted epidermal l-tryptophan metabolism in vitiligo affects immune response and ROS scavenging by Fenton chemistry, part 1: epidermal H2O2/ONOO(−)-mediated stress abrogates tryptophan hydroxylase and Dopa decarboxylase activities, leading to low serotonin and melatonin levels. FASEB J 26(6):2457–2470 Kramer HJ, Podobinska M, Bartsch A, Battmann A, Thoma W, Bernd A et al (2005) Malassezin, a novel agonist of the aryl hydrocarbon receptor from the yeast Malassezia furfur, induces apoptosis in primary human melanocytes. Chembiochem 6(5):860–865 Gaitanis G, Magiatis P, Stathopoulou K, Bassukas ID, Alexopoulos EC, Velegraki A et al (2008) AhR ligands, malassezin, and indolo[3,2-b]carbazole are selectively produced by Malassezia furfur strains isolated from seborrheic dermatitis. J Invest Dermatol 128(7):1620–1625 Gaido KW, Maness SC, Leonard LS, Greenlee WF (1992) 2,3,7,8-Tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors-alpha and -beta 2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control. J Biol Chem 267(34):24591–24595 Loertscher JA, Lin TM, Peterson RE, Allen-Hoffmann BL (2002) In utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin causes accelerated terminal differentiation in fetal mouse skin. Toxicol Sci 68(2):465–472 Sutter CH, Bodreddigari S, Campion C, Wible RS, Sutter TR (2011) 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases the expression of genes in the human epidermal differentiation complex and accelerates epidermal barrier formation. Toxicol Sci 124(1):128–137 Loertscher JA, Sattler CA, Allen-Hoffmann BL (2001) 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters the differentiation pattern of human keratinocytes in organotypic culture. Toxicol Appl Pharmacol 175(2):121–129 Villano CM, Murphy KA, Akintobi A, White LA (2006) 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells. Toxicol Appl Pharmacol 210(3):212–224 Naldi L, Chatenoud L, Linder D, Belloni FA, Peserico A, Virgili AR et al (2005) Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case–control study. J Invest Dermatol 125(1):61–67 D’Cruz D (2000) Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 112–113:421–432 Rieber N, Belohradsky BH (2010) AHR activation by tryptophan-pathogenic hallmark of Th17-mediated inflammation in eosinophilic fasciitis, eosinophilia-myalgia-syndrome, and toxic oil syndrome? Immunol Lett 128(2):154–155